Adenopure Tablet
Marketer
Manith Healthcare Pvt Ltd
Salt Composition
S-Adenosyl L-Methoinine Disulfate Tosylate (400mg)
Overview Adenopure Tablet
Hepaticaid tablets are indicated for managing liver conditions characterized by insufficient bile production (intrahepatic cholestasis). This medication safeguards liver cells against harmful substances and facilitates optimal liver function. Hepaticaid tablets can be ingested with or without food. Dosage is determined by disease severity and patient weight; while generally swallowed whole, tablets may be divided to achieve the prescribed dose. Consistent use is crucial for maximum therapeutic effect, potentially requiring several months or longer of continuous treatment. Continue as directed, even after symptom resolution. Common, albeit not universal, side effects include headache, nausea, vomiting, gastrointestinal upset (diarrhea or constipation), and sleep disturbances. Report any persistent or concerning side effects to your physician; diarrhea may necessitate dosage adjustment or treatment discontinuation. Maintain adequate hydration, especially if experiencing severe diarrhea or constipation. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding before commencing treatment. Hepaticaid may interact with other medications; disclose all concurrent medications to your physician. Alcohol consumption should be avoided due to the potential for increased side effects.
Uses of Adenopure Tablet
Hepatic disorder management
Major Benefits of Adenopure Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Adenopure Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
Common Side effects of Adenopure Tablet:
- Headache
- Dizziness
- Vomiting
- Upset stomach
- Diarrhea
- Constipation
- Insomnia (difficulty in sleeping)
How to use Adenopure Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Adenopure Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Adenopure Tablets can be administered with or without food, although consistent timing is recommended.
How Adenopure Tablet works:
Adenopure Tablets provide S-Adenosyl-L-methionine disulfate tosylate (SAMe), a dietary supplement supporting hepatic health. This formulation helps replenish glutathione levels in the liver, mitigating liver injury. SAMe's crucial role in numerous bodily processes, including the regulation of liver cell growth, death, and maturation, makes it a valuable aid. Given the impaired liver function characteristic of hepatic disorders, Adenopure Tablets offer a supportive nutritional approach.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Adenopure Tablet ingestion is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Adenopure Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Adenopure Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Adenopure Tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding Adenopure Tablet use in individuals with kidney disorders is scarce. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Patients with hepatic impairment can safely use Adenopure tablets without requiring any dosage modification.
What if you forget to take Adenopure Tablet :
Should you forget to take your Adenopure Tablet, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Adenopure Tablet
| Label | Value |
|---|---|
| Chemical Category | Thio-deoxyribonucleosides |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |



